A rapid immunochromatographic testing platform utilizing colloidal gold technology for point-of-care and laboratory diagnostics. The system provides quick visual results for various clinical markers and infectious disease screening.
Manufactured by
Shenzhen, China
Founded in 2008, Shenzhen YHLO Biotech Co., Ltd. (YHLO) is a publicly listed company on the Science and Technology Innovation Board (stock code: 688575). Based in Shenzhen, YHLO excels in the research, development, production, sales, and service of in vitro diagnostic (IVD) products. Recognized as a national high-tech enterprise with extensive independent intellectual property rights, YHLO has earned numerous accolades, including being named a National Intellectual Property Demonstration Enterprise and one of Shenzhen's Top 70 Innovative Enterprises. YHLO utilizes six advanced IVD technology platforms, including chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. With a portfolio of over 300 products addressing areas such as autoimmunity, reproductive health, infection, liver disease, and respiratory diseases, YHLO's products are widely implemented across hospitals, community clinics, and third-party testing centers, with a coverage rate exceeding 70% in China's top-tier hospitals. While firmly rooted in the domestic market, YHLO actively expands its international presence, with products exported to nearly 115 countries and regions, gaining recognition and trust from global customers. YHLO has made substantial investments in research and development, establishing research centers in Tokyo, Japan; Wuhan, China; and Changsha, China, as well as setting up a production base in Xiangtan, China. As of August 30, 2024, the company has filed for 681 patents, including 58 PCT patents, 367 invention patents, 167 utility model patents, and 22 design patents. YHLO prioritizes the integration of industry, academia, and research, establishing collaborative laboratories with prestigious institutions such as Peking University, the Institute of Biophysics of the Chinese Academy of Sciences, the Chinese University of Hong Kong (Shenzhen), the Southern University of Science and Technology, the Third People's Hospital of Shenzhen, Huazhong University of Science and Technology, and the National Innovation Center for High-Performance Medical Devices. YHLO adheres to the mission of Focus on healthcare, better life with technology, consistently striving for excellence and delivering outstanding products and services for human health, with the goal of being a leading enterprise in the life sciences and a global leader in in vitro diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangzhou Wondfo Biotech Co., Ltd.
China · 3 relevant products
SA Scientific Ltd.
United States · 1 relevant product
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
Xenta Biomedical Science Co.,Ltd
China · 3 relevant products
Biomerica, Inc.
United States · 1 relevant product
Shenzhen Dymind Biotechnology Co.,Ltd.
China · 1 relevant product
Hangzhou Pefectech Biotechnology Co., Ltd.
China · 8 relevant products
Assure Tech. (Hangzhou) Co., Ltd.
China · 4 relevant products
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
38 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 88 closest product alternatives
Guangzhou Wondfo Biotech Co., Ltd. · China
Point-of-care testing platform utilizing colloidal gold technology for rapid diagnostic applications. Enables quick detection and quantification of analytes in clinical settings without requiring laboratory infrastructure.
SA Scientific Ltd. · United States
Diagnostic test platform utilizing colloidal gold technology for rapid pathogen and infectious disease detection. Applicable across fertility, infectious disease, and respiratory illness diagnostic applications.
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Guangzhou Wondfo Biotech Co., Ltd. · China
Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Xenta Biomedical Science Co.,Ltd · China
An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Point-of-care testing platform for rapid disease detection and immediate clinical decision-making at bedside or clinic.
Hangzhou Pefectech Biotechnology Co., Ltd. · China
Colloidal gold platform immunoassay for detection of various clinical markers and disease indicators. Provides versatile testing options for diverse diagnostic applications.
Hangzhou Pefectech Biotechnology Co., Ltd. · China
Colloidal gold platform immunoassay designed for detection and diagnosis of gastrointestinal disease markers. Enables rapid screening in clinical laboratory settings.
Hangzhou Pefectech Biotechnology Co., Ltd. · China
Rapid in vitro diagnostic test kits based on colloidal gold platform technology for detection of various diseases. The platform covers multiple clinical categories including drug of abuse, gastrointestinal, sexually transmitted, respiratory, and tropical diseases.
Assure Tech. (Hangzhou) Co., Ltd. · China
POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.
76 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products